INS and Hyperglycemia: However, after 10 days of Sox17 overexpression, we observed broad loss of proinsulin throughout the secretory system (Figure 5L–W) correlated with hyperglycemia and an increase of proinsulin in the plasma, suggesting that Sox17 overexpression was causing constitutive secretion of proinsulin.